Luminar Provides Q2 Update; Raises Guidance
Luminar (NASDAQ: LAZR) reported impressive Q2 2022 results with revenue of $9.9 million, a 57% increase year-over-year. The demand from leading automakers is rising as the company works towards the series production launch of its Iris lidar technology. Luminar is building a new automated facility to accommodate accelerated growth, raising its full-year guidance for major commercial program wins to 60% YoY growth. The company remains on track to achieve its 2022 milestones, including the beta release of its Sentinel software and the launch of Iris by the end of the year.
- Q2 revenue of $9.9 million, up 57% YoY.
- Increased full-year guidance for major commercial program wins from 40% to 60% YoY.
- On track to meet series production readiness for Iris by end of 2022.
- New automated facility being planned to support higher production volumes.
- Successful completion of the first phase of a major OEM program.
- None.
Increasing Growth Rate for Major Commercial Program Wins and Order Book; Raising Revenue Guidance
“The most advanced automakers’ demand for
Today,
Luminar’s Major 2022 Milestones - Q2 Highlights:
-
Iris Industrialization for Series Production:
Luminar remains on track to meet its target of achieving series production readiness for Iris lidar and core software by the end of 2022. In the second quarter,Luminar began preparing for a new higher-volume, fully dedicated manufacturing facility with Celestica, which will feature increased levels of automation and drive scalable capacity to serve increasing demand. -
Software:
Luminar remains on track to a beta release of Sentinel by the end of 2022. In Q2,Luminar conducted live demo drives at TechCrunch Mobility, demonstrating the higher-confidence detection and collision-avoidance capability of lidar-based Proactive Safety™ compared to today’s camera and radar-based ADAS systems. -
Commercial Programs:
Luminar is raising full-year guidance for growth of major commercial program wins from40% to60% YoY growth. In Q2,Luminar successfully completed the first phase of another major OEM program.Luminar also announced a collaboration with ECARX1, a global mobility tech company and key strategic partner to variousGeely ecosystem brands, to advance the adoption of lidar-based vehicle safety and autonomy inChina and beyond. -
Forward-Looking Order Book:
Luminar is raising full-year guidance for growth of its forward-looking order book from40% YoY to60% YoY growth.
Key Q2 2022 Financials:
-
Revenue: Q2 revenue of
, ahead of company expectations and up$9.9 million 57% YoY, and45% compared to the prior quarter. -
GAAP and Non-GAAP net loss: Q2 GAAP net loss was
, or$95.2 million per share; Q2 Non-GAAP net loss was$(0.27) , or$65.0 million per share.$(0.18) -
Cash,
Cash Equivalents and Marketable Securities were as of$605.3 million June 30, 2022 . Q2 cash spend (operating cash flow less capital expenditures) was . During the quarter, the company repurchased$56.5 million of its shares. Maintaining prior cash spend guidance of 2022 cash spend moderately higher than 2021 ($37.0 million ).$155 million -
Full-Year 2022 Financial Outlook: Raising full-year 2022 revenue outlook to
to$40 million , up from$45 million .$40 million
1 | See press release: https://www.luminartech.com/ecarx/ |
Webcast Details:
Founder and CEO
- What: video webcast featuring quarterly business and financial update and live Q&A
-
Date: today,
August 8, 2022 -
Time:
2:00 p.m. PDT (5:00 p.m. EDT )
A live webcast of the event will be available on Luminar’s investor site at https://luminartech.com/quarterlyreview. A replay of the webcast will be available following the presentation. For additional information or to be added to our investor distribution list, please visit us at https://investors.luminartech.com/ir-resources/email-alerts.
Non-GAAP Financial Measures
In addition to disclosing financial measures prepared in accordance with
This release includes non-GAAP financial measures, including non-GAAP net loss, Order Book, and Cash Spend. Non-GAAP net loss is defined as GAAP net loss plus stock-based compensation expense, plus amortization of intangible assets, plus legal reserve related to employee matters, plus transaction costs relating to acquisition activities, plus expenses related to registration statement on Form S-1 on behalf of selling stockholders, plus change in fair value of warrant liabilities, plus benefit from income taxes.
Order Book is defined as the forward-looking cumulative sales estimates of Luminar’s hardware and software products over the lifetime of given programs which Luminar’s technology is integrated into or provided for, based primarily on projected/actual contractual pricing terms and good faith estimates of “take rates” of Luminar’s technology on vehicles. Such anticipated programs and volumes/take rates are based on commitments by our partners that are dependent on successful performance through development and validation and entering definitive purchase orders for series production, which may change for a variety of reasons as disclosed herein and other
Forward-Looking Statements
Certain statements included in this press release that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “aims,” “believe,” “may,” “will,” “estimate,” “set,” “continue,” “towards,” “anticipate,” “intend,” “expect,” “should,” “would,” “forward,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding the expected achievement and timing of series production readiness for Iris lidar and core software, the expected timing and impact of the new, high-volume manufacturing facility, the expected timing of a Sentinel beta, the expected growth in 2022 of Luminar’s forward-looking order book and major commercial wins, and expectations for 2022 revenue growth and cash expenditure. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of
About
Condensed Consolidated Balance Sheets (In thousands) (Unaudited) |
|||||||
|
|
|
|
||||
ASSETS |
|
|
|
||||
Current Assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
76,717 |
|
|
$ |
329,977 |
|
Restricted cash |
|
980 |
|
|
|
725 |
|
Marketable securities |
|
528,548 |
|
|
|
462,141 |
|
Accounts receivable |
|
9,279 |
|
|
|
13,013 |
|
Inventory |
|
9,349 |
|
|
|
10,342 |
|
Prepaid expenses and other current assets |
|
46,178 |
|
|
|
29,195 |
|
Total current assets |
|
671,051 |
|
|
|
845,393 |
|
Property and equipment, net |
|
19,946 |
|
|
|
11,009 |
|
Operating lease right-of-use assets |
|
17,447 |
|
|
|
9,145 |
|
Intangible assets, net |
|
23,458 |
|
|
|
2,424 |
|
|
|
18,465 |
|
|
|
3,110 |
|
Other non-current assets |
|
25,230 |
|
|
|
12,455 |
|
Total assets |
$ |
775,597 |
|
|
$ |
883,536 |
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
20,119 |
|
|
$ |
14,419 |
|
Accrued and other current liabilities |
|
31,504 |
|
|
|
19,844 |
|
Operating lease liabilities |
|
6,217 |
|
|
|
4,735 |
|
Total current liabilities |
|
57,840 |
|
|
|
38,998 |
|
Warrant liabilities |
|
4,351 |
|
|
|
31,230 |
|
Convertible senior notes |
|
610,575 |
|
|
|
608,957 |
|
Operating lease liabilities, non-current |
|
12,464 |
|
|
|
5,768 |
|
Other non-current liabilities |
|
1,806 |
|
|
|
598 |
|
Total liabilities |
|
687,036 |
|
|
|
685,551 |
|
Stockholders’ equity: |
|
|
|
||||
Class A common stock |
|
28 |
|
|
|
27 |
|
Class B common stock |
|
10 |
|
|
|
10 |
|
Additional paid-in capital |
|
1,413,064 |
|
|
|
1,257,214 |
|
Accumulated other comprehensive loss |
|
(6,005 |
) |
|
|
(908 |
) |
|
|
(312,477 |
) |
|
|
(235,871 |
) |
Accumulated deficit |
|
(1,006,059 |
) |
|
|
(822,487 |
) |
Total stockholders’ equity |
|
88,561 |
|
|
|
197,985 |
|
Total liabilities and stockholders’ equity |
$ |
775,597 |
|
|
$ |
883,536 |
|
Condensed Consolidated Statements of Operations (In thousands, except share and per share data) (Unaudited) |
|||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Revenue: |
|
|
|
|
|
|
|
||||||||
Products |
$ |
1,798 |
|
|
$ |
1,977 |
|
|
$ |
3,339 |
|
|
$ |
4,910 |
|
Services |
|
8,134 |
|
|
|
4,332 |
|
|
|
13,448 |
|
|
|
6,712 |
|
Total revenue |
|
9,932 |
|
|
|
6,309 |
|
|
|
16,787 |
|
|
|
11,622 |
|
Cost of sales: |
|
|
|
|
|
|
|
||||||||
Products |
|
16,987 |
|
|
|
3,720 |
|
|
|
28,805 |
|
|
|
9,029 |
|
Services |
|
11,105 |
|
|
|
4,133 |
|
|
|
15,941 |
|
|
|
6,463 |
|
Total cost of sales |
|
28,092 |
|
|
|
7,853 |
|
|
|
44,746 |
|
|
|
15,492 |
|
Gross loss |
|
(18,160 |
) |
|
|
(1,544 |
) |
|
|
(27,959 |
) |
|
|
(3,870 |
) |
Operating expenses: |
|
|
|
|
|
|
|
||||||||
Research and development |
|
40,941 |
|
|
|
19,913 |
|
|
|
74,050 |
|
|
|
33,923 |
|
Sales and marketing |
|
7,189 |
|
|
|
3,507 |
|
|
|
16,587 |
|
|
|
6,142 |
|
General and administrative |
|
38,150 |
|
|
|
19,237 |
|
|
|
68,175 |
|
|
|
29,510 |
|
Total operating expenses |
|
86,280 |
|
|
|
42,657 |
|
|
|
158,812 |
|
|
|
69,575 |
|
Loss from operations |
|
(104,440 |
) |
|
|
(44,201 |
) |
|
|
(186,771 |
) |
|
|
(73,445 |
) |
Other income (expense), net: |
|
|
|
|
|
|
|
||||||||
Change in fair value of warrant liabilities |
|
11,733 |
|
|
|
6,928 |
|
|
|
7,876 |
|
|
|
(39,721 |
) |
Interest expense and other |
|
(3,148 |
) |
|
|
(288 |
) |
|
|
(6,428 |
) |
|
|
(488 |
) |
Interest income and other |
|
603 |
|
|
|
731 |
|
|
|
2,142 |
|
|
|
901 |
|
Total other income (expense), net |
|
9,188 |
|
|
|
7,371 |
|
|
|
3,590 |
|
|
|
(39,308 |
) |
Loss before provision (benefit from) for income taxes |
|
(95,252 |
) |
|
|
(36,830 |
) |
|
|
(183,181 |
) |
|
|
(112,753 |
) |
Provision for (benefit from) income taxes |
|
(13 |
) |
|
|
— |
|
|
|
391 |
|
|
|
— |
|
Net loss |
$ |
(95,239 |
) |
|
$ |
(36,830 |
) |
|
$ |
(183,572 |
) |
|
$ |
(112,753 |
) |
Net loss per share: |
|
|
|
|
|
|
|
||||||||
Basic and diluted |
$ |
(0.27 |
) |
|
$ |
(0.11 |
) |
|
$ |
(0.52 |
) |
|
$ |
(0.33 |
) |
Shares used in computing net loss per share: |
|
|
|
|
|
|
|
||||||||
Basic and diluted |
|
352,054,529 |
|
|
|
340,255,023 |
|
|
|
350,378,494 |
|
|
|
336,641,349 |
|
Condensed Consolidated Statements of Cash Flows (In thousands) (Unaudited) |
|||||||
|
Six Months Ended |
||||||
|
2022 |
|
2021 |
||||
Cash flows from operating activities: |
|
|
|
||||
Net loss |
$ |
(183,572 |
) |
|
$ |
(112,753 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
||||
Depreciation and amortization |
|
2,544 |
|
|
|
1,332 |
|
Noncash lease expense related to operating lease right-of-use assets |
|
2,139 |
|
|
|
1,748 |
|
Amortization of premium on marketable securities |
|
919 |
|
|
|
602 |
|
Change in fair value of warrants |
|
(7,876 |
) |
|
|
39,721 |
|
Vendor stock-in lieu of cash program |
|
19,916 |
|
|
|
— |
|
Amortization of debt discount and issuance costs |
|
1,618 |
|
|
|
— |
|
Impairment of inventories |
|
4,778 |
|
|
|
1,453 |
|
Share-based compensation |
|
65,323 |
|
|
|
16,367 |
|
Product warranty and other |
|
171 |
|
|
|
572 |
|
Changes in operating assets and liabilities: |
|
|
|
||||
Accounts receivable |
|
7,038 |
|
|
|
3,527 |
|
Inventories |
|
(2,814 |
) |
|
|
(2,640 |
) |
Prepaid expenses and other current assets |
|
(2,417 |
) |
|
|
(8,469 |
) |
Other non-current assets |
|
(532 |
) |
|
|
(1,490 |
) |
Accounts payable |
|
7,392 |
|
|
|
854 |
|
Accrued and other current liabilities |
|
1,106 |
|
|
|
2,652 |
|
Other non-current liabilities |
|
(931 |
) |
|
|
(1,659 |
) |
Net cash used in operating activities |
|
(85,198 |
) |
|
|
(58,183 |
) |
Cash flows from investing activities: |
|
|
|
||||
Acquisition of Freedom Photonics |
|
(2,759 |
) |
|
|
— |
|
Acquisition of Solfice assets |
|
(2,001 |
) |
|
|
— |
|
Purchases of marketable securities |
|
(270,440 |
) |
|
|
(376,289 |
) |
Proceeds from maturities of marketable securities |
|
147,053 |
|
|
|
169,619 |
|
Proceeds from sales of marketable securities |
|
50,315 |
|
|
|
36,937 |
|
Purchases of property and equipment |
|
(7,491 |
) |
|
|
(2,710 |
) |
Advances for capital projects and equipment |
|
(1,673 |
) |
|
|
— |
|
Net cash used in investing activities |
|
(86,996 |
) |
|
|
(172,443 |
) |
Cash flows from financing activities: |
|
|
|
||||
Proceeds from exercise of warrants |
|
— |
|
|
|
153,927 |
|
Proceeds from exercise of stock options |
|
1,791 |
|
|
|
2,812 |
|
Payments of employee taxes related to stock-based awards |
|
(1,724 |
) |
|
|
(140 |
) |
Repurchase of common stock and redemption of warrants |
|
(80,878 |
) |
|
|
(2 |
) |
Other financing activities |
|
— |
|
|
|
(276 |
) |
Net cash provided by (used in) financing activities |
|
(80,811 |
) |
|
|
156,321 |
|
Net decrease in cash, cash equivalents and restricted cash |
|
(253,005 |
) |
|
|
(74,305 |
) |
Beginning cash, cash equivalents and restricted cash |
|
330,702 |
|
|
|
209,719 |
|
Ending cash, cash equivalents and restricted cash |
$ |
77,697 |
|
|
$ |
135,414 |
|
Reconciliation of GAAP Cost of Sales to Non-GAAP Cost of Sales (In thousands) (Unaudited) |
|||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
GAAP cost of sales |
$ |
28,092 |
|
|
$ |
7,853 |
|
|
$ |
44,746 |
|
|
$ |
15,492 |
|
Non-GAAP adjustments: |
|
|
|
|
|
|
|
||||||||
Stock-based compensation |
|
(6,989 |
) |
|
|
(1,127 |
) |
|
|
(8,775 |
) |
|
|
(1,210 |
) |
Amortization of intangible assets |
|
(259 |
) |
|
|
— |
|
|
|
(303 |
) |
|
|
— |
|
Non-GAAP cost of sales |
$ |
20,844 |
|
|
$ |
6,726 |
|
|
$ |
35,668 |
|
|
$ |
14,282 |
|
Reconciliation of GAAP Gross Loss to Non-GAAP Gross Loss (In thousands) (Unaudited) |
|||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
GAAP gross loss |
$ |
(18,160 |
) |
|
$ |
(1,544 |
) |
|
$ |
(27,959 |
) |
|
$ |
(3,870 |
) |
Non-GAAP adjustments: |
|
|
|
|
|
|
|
||||||||
Stock-based compensation |
|
6,989 |
|
|
|
1,127 |
|
|
|
8,775 |
|
|
|
1,210 |
|
Amortization of intangible assets |
|
259 |
|
|
|
— |
|
|
|
303 |
|
|
|
— |
|
Non-GAAP gross loss |
$ |
(10,912 |
) |
|
$ |
(417 |
) |
|
$ |
(18,881 |
) |
|
$ |
(2,660 |
) |
Reconciliation of GAAP Operating Expenses to Non-GAAP Operating Expenses (In thousands) (Unaudited) |
|||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
GAAP operating expenses |
$ |
86,280 |
|
|
$ |
42,657 |
|
|
$ |
158,812 |
|
|
$ |
69,575 |
|
Non-GAAP adjustments: |
|
|
|
|
|
|
|
||||||||
Stock-based compensation |
|
(31,636 |
) |
|
|
(13,403 |
) |
|
|
(56,548 |
) |
|
|
(15,157 |
) |
Amortization of intangible assets |
|
(534 |
) |
|
|
— |
|
|
|
(553 |
) |
|
|
— |
|
Reserve related to employee matters |
|
(2,000 |
) |
|
|
— |
|
|
|
(2,000 |
) |
|
|
— |
|
Transaction costs relating to acquisition activities |
|
(524 |
) |
|
|
— |
|
|
|
(2,037 |
) |
|
|
— |
|
Expenses related to registration statement on Form S-1 on behalf of selling stockholders |
|
— |
|
|
|
(1,521 |
) |
|
|
— |
|
|
|
(1,982 |
) |
Non-GAAP operating expenses |
$ |
51,586 |
|
|
$ |
27,733 |
|
|
$ |
97,674 |
|
|
$ |
52,436 |
|
Reconciliation of GAAP Net Loss to Non-GAAP Net Loss (In thousands, except share and per share data) (Unaudited) |
|||||||||||||||
|
Three Months Ended |
|
Six Months Ended |
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
GAAP net loss |
$ |
(95,239 |
) |
|
$ |
(36,830 |
) |
|
$ |
(183,572 |
) |
|
$ |
(112,753 |
) |
Non-GAAP adjustments: |
|
|
|
|
|
|
|
||||||||
Stock-based compensation |
|
38,625 |
|
|
|
14,530 |
|
|
|
65,323 |
|
|
|
16,367 |
|
Amortization of intangible assets |
|
793 |
|
|
|
— |
|
|
|
856 |
|
|
|
— |
|
Legal reserve related to employee matters |
|
2,000 |
|
|
|
— |
|
|
|
2,000 |
|
|
|
— |
|
Transaction costs relating to acquisition activities |
|
524 |
|
|
|
— |
|
|
|
2,037 |
|
|
|
— |
|
Expenses related to registration statement on Form S-1 on behalf of selling stockholders |
|
— |
|
|
|
1,521 |
|
|
|
— |
|
|
|
1,982 |
|
Change in fair value of warrant liabilities |
|
(11,733 |
) |
|
|
(6,928 |
) |
|
|
(7,876 |
) |
|
|
39,721 |
|
Provision for income taxes |
|
— |
|
|
|
— |
|
|
|
165 |
|
|
|
— |
|
Non-GAAP net loss |
$ |
(65,030 |
) |
|
$ |
(27,707 |
) |
|
$ |
(121,067 |
) |
|
$ |
(54,683 |
) |
GAAP net loss per share: |
|
|
|
|
|
|
|
||||||||
Basic and diluted |
$ |
(0.27 |
) |
|
$ |
(0.11 |
) |
|
$ |
(0.52 |
) |
|
$ |
(0.33 |
) |
Non-GAAP net loss per share: |
|
|
|
|
|
|
|
||||||||
Basic and diluted |
$ |
(0.18 |
) |
|
$ |
(0.08 |
) |
|
$ |
(0.35 |
) |
|
$ |
(0.16 |
) |
Shares used in computing GAAP net loss per share: |
|
|
|
|
|
|
|
||||||||
Basic and diluted |
|
352,054,529 |
|
|
|
340,255,023 |
|
|
|
350,378,494 |
|
|
|
336,641,349 |
|
Shares used in computing Non-GAAP net loss per share: |
|
|
|
|
|
|
|
||||||||
Basic and diluted |
|
352,054,529 |
|
|
|
340,255,023 |
|
|
|
350,378,494 |
|
|
|
336,641,349 |
|
Reconciliation of GAAP Operating Cash Flow to Non-GAAP Free Cash Flow (In thousands) (Unaudited) |
|||||||
|
Six Months Ended |
||||||
|
2022 |
|
2021 |
||||
GAAP operating cash flow |
$ |
(85,198 |
) |
|
$ |
(58,183 |
) |
Non-GAAP adjustments: |
|
|
|
||||
Capital expenditure |
|
(9,164 |
) |
|
|
(2,710 |
) |
Non-GAAP free cash flow |
$ |
(94,362 |
) |
|
$ |
(60,893 |
) |
Summary of Stock-Based Compensation and Intangibles Amortization (In thousands) (Unaudited) |
|||||||||||
Three Months Ended |
|||||||||||
|
|
|
|
||||||||
|
Stock-Based
|
|
Intangibles
|
|
Stock-Based
|
|
Intangibles
|
||||
Cost of Sales |
$ |
6,989 |
|
$ |
259 |
|
$ |
1,127 |
|
$ |
— |
Research and development |
|
8,714 |
|
|
201 |
|
|
5,663 |
|
|
— |
Sales and marketing |
|
2,741 |
|
|
333 |
|
|
934 |
|
|
— |
General and administrative |
|
20,181 |
|
|
— |
|
|
6,806 |
|
|
— |
Total |
$ |
38,625 |
|
$ |
793 |
|
$ |
14,530 |
|
$ |
— |
|
Six Months Ended |
||||||||||
|
|
|
|
||||||||
|
Stock-Based
|
|
Intangibles
|
|
Stock-Based
|
|
Intangibles
|
||||
Cost of Sales |
$ |
8,775 |
|
$ |
303 |
|
$ |
1,210 |
|
$ |
— |
Research and development |
|
15,816 |
|
|
201 |
|
|
6,425 |
|
|
— |
Sales and marketing |
|
5,609 |
|
|
352 |
|
|
1,120 |
|
|
— |
General and administrative |
|
35,123 |
|
|
— |
|
|
7,612 |
|
|
— |
Total |
$ |
65,323 |
|
$ |
856 |
|
$ |
16,367 |
|
$ |
— |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220808005544/en/
Media Relations:
Press@luminartech.com
Investor Relations:
trey.campbell@luminartech.com
Source:
FAQ
What are Luminar's Q2 2022 revenue results?
What is Luminar's updated guidance for commercial program growth in 2022?
When is the series production launch of Iris scheduled?
What new facility is Luminar planning?